Dispensation Of Schedule II-IV Drugs Must Be Reported Within A Week Under New Law
This article was originally published in The Pink Sheet Daily
The National All Schedules Prescription Electronic Reporting Act authorizes $60 mil. over five years for states to create or augment Rx monitoring programs.
You may also be interested in...
The bills would ease restrictions on exporting controlled substances and limitations on medical practices that treat drug-addicted patients.
The House and Senate could vote on the "National All Schedules Prescription Electronic Reporting Act" following an agreement by committees to send an identical version to their respective floors. Under HR 1132, states would receive grants to create or augment monitoring systems to track prescriptions of Schedule II-IV drugs across state lines.
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.